New antidepressant drugs.
Antidepressants recently marketed, under development, or in clinical trials are reviewed in terms of the neurotransmitter systems they preferentially affect, dosage ranges, side effect profiles, and comparative efficacy. The development of these agents contributes not only to treatment efforts but to our understanding of the mechanisms underlying depression.